Pharmacogenomics and Personalized Medicine in Type 2 Diabetes Mellitus: Potential Implications for Clinical Practice

QR Code

Pharmacogenomics and Personalized Medicine in Type 2 Diabetes Mellitus: Potential Implications for Clinical Practice

Poongothai Venkatachalapathy,1 Sruthi Padhilahouse,1 Mohan Sellappan,1 Tharunika Subramanian,2 Shilia Jacob Kurian,3 Sonal Sekhar Miraj,3 Mahadev Rao,3 Ashwin Ashok Raut,4 Rupinder Kaur Kanwar,4 Jitendra Singh,4 Sagar Khadanga,5 Sukumar Mondithoka,5 Murali Munisamy4 1Department of Pharmacy Practice,...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Venkatachalapathy P, Padhilahouse S, Sellappan M, Subramanian T, Kurian SJ, Miraj SS, Rao M, Raut AA, Kanwar RK, Singh J, Khadanga S, Mondithoka S, Munisamy M
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2021
Sujets:	pharmacogenomics personalized medicine type 2 diabetes antidiabetic drugs Therapeutics. Pharmacology RM1-950
Accès en ligne:	https://doaj.org/article/5053c2f23b274392ac1de3c5ab3daa10
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

The pharmacogenomics journal
Publié: (2001)

Clinical applications of pharmacogenomics
par: Quiñones,Luis, et autres
Publié: (2017)

Pharmacogenomics and Rheumatological Practice
par: Chuanhui Xu, et autres
Publié: (2021)

Pharmacogenomic Testing and Patient Perception Inform Pain Pharmacotherapy
par: Feng-Hua Loh, et autres
Publié: (2021)

American journal of pharmacogenomics genomics-related research in drug development and clinical practice.
Publié: (2001)

Conversion Disorder in a Pharmacogenomics, Polypharmacy Patient: Case Report
par: Michael J. Schuh, et autres
Publié: (2021)

Pharmacogenomics of hyaluronic acid
par: Elena E. Vaiman, et autres
Publié: (2021)

Anti-platelet drugs, pharmacogenomics and stent thrombosis: What’s new?
par: John Benjamin
Publié: (2017)

Editorial: NSAIDs Pharmacogenomics
par: José A. G. Agúndez, et autres
Publié: (2021)

Utilizing a Human–Computer Interaction Approach to Evaluate the Design of Current Pharmacogenomics Clinical Decision Support
par: Amanda L. Elchynski, et autres
Publié: (2021)

PharmVIP: A Web-Based Tool for Pharmacogenomic Variant Analysis and Interpretation
par: Jittima Piriyapongsa, et autres
Publié: (2021)

A Comprehensive Review of <i>HLA</i> and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine
par: Chiraphat Kloypan, et autres
Publié: (2021)

Unmanaged Pharmacogenomic and Drug Interaction Risk Associations with Hospital Length of Stay among Medicare Advantage Members with COVID-19: A Retrospective Cohort Study
par: Kristine Ashcraft, et autres
Publié: (2021)

Aplicaciones médicas de los descubrimientos genómicos
par: Cruz-Coke M,Ricardo
Publié: (2001)

Farmacogenómica de los anticoagulantes orales: la importancia de establecer algoritmos de dosificación en población chilena
par: Guzmán,Neftalí, et autres
Publié: (2020)

Assessment of Clinical Experience of Triple Drug Fixed-dose Combination of Glimepiride, Metformin and Voglibose in the Management of Type 2 Diabetes Mellitus: A Retrospective Study
par: Ganapathi Bantwal, et autres
Publié: (2021)

PHYTOCHEMICAL ASSESSMENT, TOTAL PHENOLIC CONTENT, CYTOTOXIC, ANTIOXIDANT AND ANTIDIABETIC ACTIVITIES OF HYOSCYAMUS INSANUS
par: Rehman-Shah,Muhammad Abdur, et autres
Publié: (2021)

Chemical characterization of the antioxidant, antihyperglycemic and antihypertensive capacities of red rice (Oryza sativa L.) whole flour
par: Silva,Andréa dos Anjos, et autres
Publié: (2020)

Pharmacogenomics and Personalized Medicine
Publié: (2009)

Race and Drug Toxicity: A Study of Three Cardiovascular Drugs with Strong Pharmacogenetic Recommendations
par: Travis J. O’Brien, et autres
Publié: (2021)

PHENOLIC COMPOSITION AND BIOLOGICAL (ANTI DIABETIC AND ANTIOXIDANT) ACTIVITIES OF DIFFERENT SOLVENT EXTRACTS OF AN ENDEMIC PLANT (HELIOTROPIUM STRIGOSUM)
par: QAYYUM,ABDUL, et autres
Publié: (2016)

PHENOLIC COMPOSITION AND BIOLOGICAL (ANTI DIABETIC AND ANTIOXIDANT) ACTIVITIES OF DIFFERENT SOLVENT EXTRACTS OF AN ENDEMIC PLANT (HELIOTROPIUM STRIGOSUM)
par: QAYYUM,ABDUL, et autres
Publié: (2016)

Challenge of diabetes mellitus and researchers’ contributions to its control
par: Odularu Ayodele T., et autres
Publié: (2021)

Expectations and educational needs of rheumatologists, rheumatology fellows and patients in the field of precision medicine in Canada, a quantitative cross-sectional and descriptive study
par: Sophie Ruel-Gagné, et autres
Publié: (2021)

Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage
par: Wilke T, et autres
Publié: (2019)

Molecular genetic features of the diabetes mellitus development and the possibility of precision therapy
par: Tatyana Yu. Demidova, et autres
Publié: (2021)

Characterization of hepatic enzyme activity in older adults with dementia: potential impact on personalizing pharmacotherapy
par: Campbell NL, et autres
Publié: (2015)

Impact of Updating Pharmacogenetic Results: Lessons Learned from the PREDICT Program
par: Michelle Liu, et autres
Publié: (2021)

Personalized medicine of non-gene-specific chemotherapies for non-small cell lung cancer
par: Wenxiao Jiang, et autres
Publié: (2021)

Phytochemical competence and pharmacological perspectives of an endangered boon—Costus speciosus (Koen.) Sm.: a comprehensive review
par: Saima Sohrab, et autres
Publié: (2021)

Multidisciplinary lifestyle management approach in patients with type 2 diabetes mellitus in real clinical practice. Results of application “Life is easy” programme in Russia
par: Svetlana I. Motkova, et autres
Publié: (2019)

Genetic Polymorphism of Drug Metabolic Gene CYPs, VKORC1, NAT2, DPYD and CHST3 of Five Ethnic Minorities in Heilongjiang Province, Northeast China
par: Zhang T, et autres
Publié: (2021)

MicroRNAs as Novel Biomarkers for P2Y12 – Inhibitors Resistance Prediction
par: Rytkin E, et autres
Publié: (2021)

Association between Genetic Variants and Cisplatin-Induced Nephrotoxicity: A Genome-Wide Approach and Validation Study
par: Zulfan Zazuli, et autres
Publié: (2021)

Flavonoids as Antidiabetic Agents
par: Yana Cahyana, et autres
Publié: (2021)

In vivo Antidiabetic Activity Evaluation of Aqueous and 80% Methanolic Extracts of Leaves of Thymus schimperi (Lamiaceae) in Alloxan-induced Diabetic Mice
par: Melesie Taye G, et autres
Publié: (2020)

Oral Nano Drug Delivery Systems for the Treatment of Type 2 Diabetes Mellitus: An Available Administration Strategy for Antidiabetic Phytocompounds
par: Nie X, et autres
Publié: (2020)

Total phenolic and flavonoid contents, antioxidant, antidiabetic and antiplasmodial activities of Garcinia forbesii King: A correlation study
par: Johanis Wairata, et autres
Publié: (2022)

Antidiabetic screening of some Indonesian marine cyanobacteria collection
par: SRI PRIATNI, et autres
Publié: (2016)

Optimizing weight control in diabetes: antidiabetic drug selection
par: Kalra S
Publié: (2010)